Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000905148-20-001056
Filing Date
2020-10-01
Accepted
2020-10-01 10:01:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 efc20-743_sc13d.htm SC 13D 353560
  Complete submission text file 0000905148-20-001056.txt   355068
Mailing Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158 415-522-0100
venBio Global Strategic Fund II L.P. (Filed by) CIK: 0001634632 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010
Business Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Subject) CIK: 0001810182 (see all company filings)

EIN.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91585 | Film No.: 201214737
SIC: 2834 Pharmaceutical Preparations